Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 10.72
+0.06 (0.52%)
Nov 17, 2025, 10:15 AM CET
Grifols Market Cap
Grifols has a market cap or net worth of €6.46 billion as of November 17, 2025. Its market cap has decreased by -1.78% in one year.
Market Cap
6.46B
Enterprise Value
9.08B
Revenue
7.52B
Ranking
n/a
PE Ratio
19.49
Stock Price
€10.72
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 6.46B, an increase of 785.46%. That is a compound annual growth rate of 11.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 6.46B | 13.62% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | 14.16B | -24.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 3.01B |
| Almirall | 2.65B |
| Faes Farma | 1.44B |
| Pharma Mar | 1.30B |
| Clínica Baviera | 696.70M |
| Oryzon Genomics | 241.68M |
| Prim, S.A. | 225.46M |
| Laboratorio Reig Jofre | 224.64M |